Keyphrases
Between-person
16%
Cancer Risk Factors
16%
Clinical Decision-making
16%
Clonal Evolution
16%
Clonal Expansion
16%
Clonal Hematopoiesis
50%
Clone Size
16%
Cloud Distribution
5%
Cytopenia
50%
Cytosis
50%
DNMT3A
33%
Education Outcomes
8%
Educational Attainment
16%
Error-corrected Sequencing
16%
Evolutionary Landscape
50%
Evolutionary Patterns
16%
Family-centered
8%
Genetic nurture
8%
Genome-wide Association Study
8%
High Growth Rate
16%
High Risk
16%
In(III)
50%
Indirect Genetic Effects
50%
Janus Kinase 2 (JAK2)
33%
Malignant Progression
16%
Myeloid Malignancies
16%
Netherlands
16%
Parent-of-origin
8%
Parent-offspring
50%
Polygenic Score
16%
Population-based
16%
S1 Lines
5%
Secondary School Level
8%
Sequential Samples
16%
SF3B1
16%
Spliceosome
16%
Splicing mutation
16%
SRSF2
16%
TP53 mutation
16%
Tumor Protein p53 (TP53)
16%
U2AF1
22%
Years of Education
8%
Biochemistry, Genetics and Molecular Biology
Clinical Decision Making
25%
Clonal Evolution
25%
Cohort Study
8%
DNMT3A
50%
Genetic Determinism
50%
Genetics
8%
Genome-Wide Association Study
8%
Hematopoiesis
100%
Janus Kinase
62%
Mental Capacity
16%
Mutated Genes
6%
Myeloid
25%
Overall Survival
12%
Platelet Count
50%
Population
100%
Prevalence
12%
Progeny
50%
SF3B1
31%
Somatic Mutation
6%
Spliceosome
62%
Thrombocytopenia
31%
Thrombocytosis
31%
Medicine and Dentistry
Hazard Ratio
18%
Hematologic Malignancy
12%
Hematopoiesis
50%
Hematopoietic Stem Cell
6%
Janus Kinase
12%
Myeloproliferative Disorder
6%
Overall Survival
12%
Platelet
50%
Population
50%
Prevalence
12%
Somatic Mutation
6%
Spliceosome
12%
Thrombocytopenia
31%
Thrombocytosis
31%
